Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...

BeOne Medicines is up 75% in 2025 but off recent highs. China’s new private insurance drug list could unlock major growth for ONC in 2026.

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

It has grown wildly, and it could keep growing.

This milestone comes at a time when India's homoeopathic sector is undergoing rapid transformation under the leadership of PM Narendra Modi, said the company.